B. B. O. Ustaalioglu Et Al. , "CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER," 39th ESMO Congress (ESMO) , vol.25, Madrid, Spain, 2014
Ustaalioglu, B. B. O. Et Al. 2014. CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. 39th ESMO Congress (ESMO) , (Madrid, Spain).
Ustaalioglu, B. B. O., Vardar, F. A., Bilici, A., Gurleyik, G., Erkol, B., & Kefeli, U., (2014). CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER . 39th ESMO Congress (ESMO), Madrid, Spain
Ustaalioglu, B. Et Al. "CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER," 39th ESMO Congress (ESMO), Madrid, Spain, 2014
Ustaalioglu, B. B. Et Al. "CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER." 39th ESMO Congress (ESMO) , Madrid, Spain, 2014
Ustaalioglu, B. B. O. Et Al. (2014) . "CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER." 39th ESMO Congress (ESMO) , Madrid, Spain.
@conferencepaper{conferencepaper, author={B. B. Oven Ustaalioglu Et Al. }, title={CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER}, congress name={39th ESMO Congress (ESMO)}, city={Madrid}, country={Spain}, year={2014}}